US Broker Ratings

Teleflex Incorporated (TFX) Investor Outlook: Analyzing a 30% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX) operates within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of approximately $5.3 billion, the company is a significant..

Edwards Lifesciences (EW) Stock Analysis: Evaluating a 7.61% Potential Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the healthcare sector specializing in medical devices, is capturing investor attention with its position in the advanced cardiovascular disease treatment market. With..

Doximity, Inc. (DOCS) Stock Analysis: Exploring an 8.99% Upside with Strong Revenue Growth in the Healthcare Sector

Doximity, Inc. (NYSE: DOCS) is capturing investor attention with its robust position within the healthcare sector. As a leading digital platform for medical professionals, Doximity offers a suite of tools..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovator with 48% Revenue Growth and Robust Buy Ratings

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector with its groundbreaking medical devices for organ transplantation. With a focus on transforming organ transplant therapy through its..

Insulet Corporation (PODD) Stock Analysis: Strong Revenue Growth and Analyst Confidence Boost Investor Outlook

Insulet Corporation (NASDAQ: PODD), a leader in the healthcare sector specializing in medical devices, has been capturing investor attention with its impressive revenue growth and robust analyst support. With a..

Pfizer, Inc. (PFE) Stock Analysis: High Dividend Yield and Potential Upside of 19.15% for Investors

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to capture investor attention with its robust portfolio of biopharmaceutical products and a compelling dividend yield. As the company..

Zoetis Inc. (ZTS) Stock Analysis: Evaluating an 18.89% Potential Upside in Animal Health

Zoetis Inc. (NYSE: ZTS), a leader in animal health, has long been a compelling choice for investors looking to capitalize on the growing demand for veterinary pharmaceuticals and diagnostics. With..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating High Growth in the Healthcare Sector

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector, with a robust market capitalization of $12.35 billion. As a pioneer in health information services, Tempus AI..

Waters Corporation (WAT) Stock Analysis: Navigating a 13.22% Potential Upside in the Diagnostics & Research Sector

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with a market cap of $20.37 billion and a notable potential..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating Volatility with a 52-Week Range of $3.20 to $877.00

Regencell Bioscience Holdings Limited (RGC) stands out in the healthcare sector, particularly within the niche of Traditional Chinese Medicine (TCM) bioscience. While its market cap hovers around $7.74 billion, the..

GSK plc (GSK) Investor Outlook: Strong Dividend Yield and Strategic Growth in Healthcare

GSK plc (GSK), a stalwart in the healthcare sector and a major player in the drug manufacturing industry, offers investors a compelling mix of steady income and strategic growth potential...

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Uncovering a 66% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector should consider Lantheus Holdings, Inc. (NASDAQ: LNTH), a company with a promising future reflected in its substantial potential upside. With a market capitalization..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating the Healthcare Distribution Landscape with an 8.78% Potential Upside

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare distribution sector, presents an intriguing proposition for investors seeking a firm foothold in the medical distribution industry. With its..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 263% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (PCVX), a clinical-stage biotechnology company, has captured the attention of investors with its pioneering approach to vaccine development. Specializing in conjugate and novel protein vaccines, Vaxcyte is at..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 70% Upside Potential Sparks Investor Interest

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a prominent entity in the biotechnology sector, dedicated to the development and commercialization of therapies for rare diseases. With a market capitalization of..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth and Challenges with a 12.95% Upside

For investors seeking opportunities in the healthcare sector, Masimo Corporation (NASDAQ: MASI) presents an intriguing proposition. As a leading player in the medical devices industry, Masimo has carved a niche..

Qiagen N.V. (QGEN) Stock Analysis: Navigating a Promising 4.77% Upside in the Diagnostics Sector

Qiagen N.V. (QGEN), a Netherlands-based leader in the healthcare sector, is carving a niche in the diagnostics and research industry with its innovative molecular insights solutions. With a market capitalization..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 35.76% Upside Potential in the Healthcare Sector

For investors keen on the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling opportunity. With a market capitalization of $13.91 billion, this American company operates within the..

Inspire Medical Systems (INSP) Stock Analysis: Harnessing a 67.93% Potential Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the medical devices industry, is capturing attention with a significant potential upside of 67.93% based on current analyst ratings. Specializing..

Alkermes plc (ALKS) Investor Outlook: Analyzing a 33.87% Upside in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, is drawing attention from investors with its significant potential upside of 33.87%, as indicated by the average target price..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds